Use

This test monitors the trough level of amikacin in serum, measuring drug concentration just before the next dose. A trough that exceeds approximately 8 µg/mL is associated with increased risk of toxicity — monitoring ensures drug clearance near the end of the dosing cycle to optimize therapy and minimize nephrotoxicity and ototoxicity.

Not provided.